Infusion Pumps Recalled – Therapy Delay or Malfunctions Cited

Patients who suffer from health conditions like cancer or anemia often must receive lifesaving medicines and fluids intravenously. When connected to medical pumps, these individuals and their healthcare providers count on those devices to function properly. Recently, however, the FDA alerted Baxter Healthcare Corporation, a maker of medical pumps, and they recalled more than 3500 of these devices due to faulty operations and failure to meet safety guidelines. The recall is categorized as a Class 1, the most serious of recalls that could result in someone being gravely injured or even killed because of a faulty pump. Because these pumps are designed to deliver fluids into sensitive areas in a person’s body, namely the vein, artery, or even spinal area, it is critical that medical personnel check their pumps and take prompt note of this recall notice.

With the recall issued, medical professionals should be on the lookout for Baxter pump models with the master drug model numbers 35700BAX or 35700ABB. If they have these pumps in their facilities, these professionals should contact the FDA or Baxter Healthcare Corporation for instructions on returning or exchanging this equipment. They should not attempt to continue using these models because these pumps fail to detect when the doors to these devices are open. The open door could cause a person’s treatment to be interrupted or delayed, which in turn could seriously sicken or even kill that patient.

Healthcare professionals can also be helped by knowing what dates the pumps were manufactured. The pumps being recalled were made between July 1, 2005 and January 15 the following year. They were made available for sale between February 20, 2013 and January 15. If buyers for doctors’ offices, hospitals, or other medical facilities purchased pumps from Baxter between these dates or know that their pumps were made during this timeframe, they should check their model numbers and return the equipment as soon as possible. Again, they should refrain from using the pumps on patients.

Source:
http://in.reuters.com/article/2014/05/01/baxter-intl-recall-idINL3N0NN3J420140501